230 related articles for article (PubMed ID: 20508518)
1. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
Voisard R; Krebs R; Baur R; Hombach V
Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
[TBL] [Abstract][Full Text] [Related]
2. Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio.
Voisard R; Alan M; von Müller L; Baur R; Hombach V
BMC Cardiovasc Disord; 2006 Apr; 6():14. PubMed ID: 16595000
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibitory effects of Ganciclovir on ICAM-1 expression and proliferation in human coronary vascular cells (SI/MPL-ratio: >1).
Voisard R; Münder U; von Müller L; Baur R; Hombach V
Med Sci Monit; 2011 Jan; 17(1):PI1-6. PubMed ID: 21169918
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratios.
Voisard R; Zellmann S; Müller F; Fahlisch F; von Müller L; Baur R; Braun J; Gschwendt J; Kountides M; Hombach V; Kamenz J
BMC Cardiovasc Disord; 2007 May; 7():15. PubMed ID: 17498286
[TBL] [Abstract][Full Text] [Related]
5. Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
Voisard R; Viola S; Kaspar V; Weber CM; von Müller L; Baur R; Gastrock-Balitsch I; Hombach V
BMC Cardiovasc Disord; 2005 May; 5(1):9. PubMed ID: 15890069
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel and sirolimus differentially affect growth and motility of endothelial progenitor cells and coronary artery smooth muscle cells.
Clever YP; Cremers B; Krauss B; Böhm M; Speck U; Laufs U; Scheller B
EuroIntervention; 2011 May; 7 Suppl K():K32-42. PubMed ID: 22027725
[TBL] [Abstract][Full Text] [Related]
7. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative profile of sirolimus and mycophenolate mofetil: impact of the SI/MPL ratio.
Voisard R; Geçgüner L; Baur R; Herter T; Hombach V
Int J Cardiol; 2005 Jul; 102(3):435-42. PubMed ID: 16004888
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
[TBL] [Abstract][Full Text] [Related]
10. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
11. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of transient exposure of paclitaxel or zotarolimus on in vitro vascular cell death, proliferation, migration, and proinflammatory biomarker expression.
Steinfeld DS; Liu AP; Hsu SH; Chan YF; Stankus JJ; Pacetti SD; Tai JT
J Cardiovasc Pharmacol; 2012 Aug; 60(2):179-86. PubMed ID: 22561362
[TBL] [Abstract][Full Text] [Related]
13. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
Fogo AS; Antonioli E; Calixto JB; Campos AH
Eur J Pharmacol; 2009 Aug; 615(1-3):50-4. PubMed ID: 19464287
[TBL] [Abstract][Full Text] [Related]
14. Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.
Sheshgiri R; Rao V; Tumiati LC; Xiao R; Prodger JL; Badiwala M; Librach C; Delgado DH
Circulation; 2008 Sep; 118(14 Suppl):S58-64. PubMed ID: 18824770
[TBL] [Abstract][Full Text] [Related]
15. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
[TBL] [Abstract][Full Text] [Related]
16. The effects of vinblastine on smooth muscle cells in vitro: evaluation of a therapeutic window for the treatment of restenosis.
Gallagher H; Carroll WM; Rochev Y
J Cardiovasc Pharmacol; 2010 Apr; 55(4):399-407. PubMed ID: 20147845
[TBL] [Abstract][Full Text] [Related]
17. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
[TBL] [Abstract][Full Text] [Related]
18. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit].
Zhang HH; Chen YC; Liang L; Zeng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):188-92. PubMed ID: 18630680
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligand induces human coronary artery smooth muscle cells proliferation and migration.
Chai H; Aghaie K; Zhou W
Surgery; 2009 Jul; 146(1):5-11. PubMed ID: 19541004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
